Skip to main content
SpringerLink
Log in

Comment on: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance”

  • Letter to the Editor
  • Published:
Applied Health Economics and Health Policy Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 23 March 2020

The Original Article was published on 20 September 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mott DJ, Hampson G, Llewelyn MJ, Mestre-Ferrandiz J, Hopkins MM. A multinational European study of patient preferences for novel diagnostics to manage antimicrobial resistance. Appl Health Econ Health Policy. 2020;18(1):69–79.

    Article  Google Scholar 

  2. Kaman WE, Andrinopoulou ER, Hays JP. Perceptions of point-of-care infectious disease testing among European medical personnel, point-of-care test kit manufacturers, and the general public. Patient Prefer Adher. 2013;7:559–77.

    Article  Google Scholar 

  3. TEMPOtest-QC - CORDIS. [cited 2020 5th February]. https://cordis.europa.eu/project/id/241742/reporting. Accessed 5 Feb 2020.

  4. Kaman WE, Elshout G, Bindels PJE, Mitsakakis K, Hays JP. Current problems associated with the microbiological point-of-care testing of respiratory tract infections in primary care. Future Microbiol. 2016;11(5):607–10.

    Article  CAS  Google Scholar 

  5. Mitsakakis K, Kaman WE, Elshout G, Specht M, Hays JP. Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice. Future Microbiol. 2018;13(10):1157–64.

    Article  CAS  Google Scholar 

  6. van Belkum A, Bachmann TT, Ludke G, Lisby JG, Kahlmeter G, Mohess A, et al. Developmental roadmap for antimicrobial susceptibility testing systems. Nat Rev Microbiol. 2019;17(1):51–62.

    Article  Google Scholar 

  7. Hays JP, Mitsakakis K, Luz S, van Belkum A, Becker K, van den Bruel A, et al. The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex ‘mix-and-match’ implementation package. Eur J Clin Microbiol Infect Dis. 2019;38(6):1015–22.

    Article  Google Scholar 

  8. Hays JP. ‘Out-of-the-box’ thinking to help stop the spread of antibiotic resistance. Future Microbiol. 2016;11:995–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre (Erasmus MC), Rotterdam, The Netherlands

    J. P. Hays

Authors
  1. J. P. Hays
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. P. Hays.

Ethics declarations

Funding

No sources of funding were used to conduct this study or prepare this manuscript.

Conflict of interest

J. P. Hays has no conflicts of interest directly relevant to this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hays, J.P. Comment on: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance”. Appl Health Econ Health Policy 18, 457–458 (2020). https://doi.org/10.1007/s40258-020-00574-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40258-020-00574-9

Search

Navigation